PL361597A1 - Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard - Google Patents

Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard

Info

Publication number
PL361597A1
PL361597A1 PL03361597A PL36159703A PL361597A1 PL 361597 A1 PL361597 A1 PL 361597A1 PL 03361597 A PL03361597 A PL 03361597A PL 36159703 A PL36159703 A PL 36159703A PL 361597 A1 PL361597 A1 PL 361597A1
Authority
PL
Poland
Prior art keywords
selenium
compounds
well
application
pharmaceutical compound
Prior art date
Application number
PL03361597A
Other languages
Polish (pl)
Other versions
PL214402B1 (en
Inventor
Jan Lubiński
Steven Narod
Stanisław Zajączek
Elżbieta Kowalska
Bohdan Górski
Tomasz Huzarski
Tomasz Byrski
Jacek Gronwald
Jowita Huzarska
Barbara Gawrońska-Szklarz
Original Assignee
Jan Lubiński
Steven Narod
Stanisław Zajączek
Elżbieta Kowalska
Bohdan Górski
Tomasz Huzarski
Tomasz Byrski
Jacek Gronwald
Jowita Huzarska
Barbara Gawrońska-Szklarz
Pomorska Akademia Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Lubiński, Steven Narod, Stanisław Zajączek, Elżbieta Kowalska, Bohdan Górski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Jowita Huzarska, Barbara Gawrońska-Szklarz, Pomorska Akademia Medyczna filed Critical Jan Lubiński
Priority to PL361597A priority Critical patent/PL214402B1/en
Priority to PCT/PL2004/000063 priority patent/WO2005013951A2/en
Priority to EP04775169A priority patent/EP1660060A2/en
Priority to AU2004263070A priority patent/AU2004263070A1/en
Priority to KR1020067002810A priority patent/KR20060066719A/en
Priority to CA002535506A priority patent/CA2535506A1/en
Priority to JP2006523155A priority patent/JP2007502270A/en
Priority to EA200600386A priority patent/EA200600386A1/en
Priority to CNA2004800231246A priority patent/CN1835740A/en
Publication of PL361597A1 publication Critical patent/PL361597A1/en
Priority to ZA200602081A priority patent/ZA200602081B/en
Publication of PL214402B1 publication Critical patent/PL214402B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL361597A 2003-08-11 2003-08-11 Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard PL214402B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
PL361597A PL214402B1 (en) 2003-08-11 2003-08-11 Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard
CA002535506A CA2535506A1 (en) 2003-08-11 2004-08-10 Pharmaceutical compositions for preventing breast and ovarian cancer
EP04775169A EP1660060A2 (en) 2003-08-11 2004-08-10 Pharmaceutical compositions for preventing breast and ovarian cancer
AU2004263070A AU2004263070A1 (en) 2003-08-11 2004-08-10 Pharmaceutical compositions for preventing breast and ovarian cancer
KR1020067002810A KR20060066719A (en) 2003-08-11 2004-08-10 Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
PCT/PL2004/000063 WO2005013951A2 (en) 2003-08-11 2004-08-10 Pharmaceutical compositions for preventing breast and ovarian cancer
JP2006523155A JP2007502270A (en) 2003-08-11 2004-08-10 Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
EA200600386A EA200600386A1 (en) 2003-08-11 2004-08-10 PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTION OF BREAST CANCER AND OVARIANS
CNA2004800231246A CN1835740A (en) 2003-08-11 2004-08-10 Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
ZA200602081A ZA200602081B (en) 2003-08-11 2006-03-10 Pharmaceutical compositions for preventing breast and ovarian cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL361597A PL214402B1 (en) 2003-08-11 2003-08-11 Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard

Publications (2)

Publication Number Publication Date
PL361597A1 true PL361597A1 (en) 2005-02-21
PL214402B1 PL214402B1 (en) 2013-07-31

Family

ID=34132453

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361597A PL214402B1 (en) 2003-08-11 2003-08-11 Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard

Country Status (10)

Country Link
EP (1) EP1660060A2 (en)
JP (1) JP2007502270A (en)
KR (1) KR20060066719A (en)
CN (1) CN1835740A (en)
AU (1) AU2004263070A1 (en)
CA (1) CA2535506A1 (en)
EA (1) EA200600386A1 (en)
PL (1) PL214402B1 (en)
WO (1) WO2005013951A2 (en)
ZA (1) ZA200602081B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032074A1 (en) * 2004-09-21 2006-03-30 Velacor Therapeutics Pty Ltd Inorganic selenium for treatment of cancer
AU2008231425B2 (en) * 2007-03-26 2014-03-20 Decode Genetics Ehf Genetic variants on Chr2 and Chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
CN100548311C (en) 2007-06-13 2009-10-14 中国科学技术大学 Application and the fast preparation method of sodium thiosulfate in preparation clinical selenium-complementing and treatment cancer drug
WO2009043106A1 (en) * 2007-10-03 2009-04-09 Velacor Therapeutics Pty Ltd Inorganic selenium and angiogenesis
US20110105342A1 (en) * 2008-03-13 2011-05-05 Jan Lubinski Method for determining reduced predisposition to cancer based on genetic profile
KR101026291B1 (en) * 2008-06-30 2011-03-31 주식회사 태강 Anticancer composition of SeO2 doped W-Mo-Li
GB0916010D0 (en) * 2009-09-11 2009-10-28 Isis Innovation JMJD2 demethylase inhibitors
WO2012067525A1 (en) 2010-11-18 2012-05-24 Pomorski Uniwersytet Medyczny Genotypes and selenium level as a markers of breast/ovarian cancer risk in brca1 mutation carriers
WO2012130609A1 (en) 2011-04-01 2012-10-04 Iasomai Ab New combination comprising n-acetyl-l-cysteine and its use
CN114984038A (en) * 2013-03-15 2022-09-02 全技术公司 Selenium-containing composition and its use for treating and preventing diseases or disorders associated with mitochondrial dysfunction
US10201559B2 (en) * 2014-03-14 2019-02-12 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
PL442921A1 (en) * 2022-11-23 2024-05-27 Read-Gene Spółka Akcyjna Reducing the risk of death in women with a hereditary predisposition to breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19825746A1 (en) * 1998-06-09 1999-12-16 Biosyn Arzneimittel Gmbh Combination of selenium-containing compounds with cytostatics

Also Published As

Publication number Publication date
EP1660060A2 (en) 2006-05-31
CA2535506A1 (en) 2005-02-17
ZA200602081B (en) 2007-05-30
JP2007502270A (en) 2007-02-08
AU2004263070A1 (en) 2005-02-17
WO2005013951A3 (en) 2005-09-15
EA200600386A1 (en) 2006-12-29
KR20060066719A (en) 2006-06-16
CN1835740A (en) 2006-09-20
WO2005013951A2 (en) 2005-02-17
PL214402B1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
EP1613308A4 (en) Novel methods for the treatment of cancer
AU2003232882A8 (en) Prostacyclin derivatives for treating cancer
HK1097410A1 (en) Analogs of benzoquinone-containing ansamycins for the treatment of cancer
EP1682529A4 (en) Methods for synthesizing quinolinone compounds
PL361597A1 (en) Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard
GB0316546D0 (en) Process for the manufacture of organic compounds
IL172629A0 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
PT1578731E (en) Process for the preparation of pyrimidine compounds
PL377464A1 (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
MXPA03008205A (en) Process for the preparation of imidazole compounds.
EP1594989A4 (en) Methods for the early diagnosis of ovarian cancer
IL168059A0 (en) Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer
AU2003223538A1 (en) Methods for the treatment of cancer
EP1556400A4 (en) Method for the preparation of 2-halo-2 -deoxyadenosine compounds from 2 -deoxyguanosine
AU2003291268A8 (en) Xanthene compounds for cancer chemotherapy
EP1646640A4 (en) Method for the preparation of highly pure 1-androstene derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2003208076A1 (en) Process for producing epoxide compound
AU2003224486A1 (en) Composition for treating cancer containing n,n-dimethylphytosphingosine
GB2405637B (en) Process for preparing of Paclitaxel
AU2003300727A1 (en) Process for synthesis of alpha-substituted acroleins
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-